Mastering Paracentesis Diagnosis: An Essential Guide for Ascites Evaluation

Ascites, the pathological accumulation of fluid within the peritoneal cavity, often signals advanced liver cirrhosis and carries a poor prognosis. Paracentesis stands as a cornerstone procedure, critical for both diagnosing the cause of ascites and providing therapeutic relief. Diagnostic paracentesis offers a crucial opportunity to analyze ascitic fluid, allowing clinicians to determine the underlying etiology of ascites and to promptly identify or exclude peritoneal fluid infections. Conversely, therapeutic paracentesis is instrumental in alleviating the uncomfortable symptoms associated with ascites by safely removing substantial volumes of fluid.

This article provides a detailed exploration of paracentesis, covering its indications, contraindications, and potential complications, offering essential knowledge for healthcare professionals. Furthermore, it highlights the indispensable role of interdisciplinary collaboration in the effective management of patients with ascites, emphasizing how early and accurate diagnosis through procedures like Paracentesis Diagnosis can significantly improve patient outcomes. Given the prevalence of liver cirrhosis as a major cause of ascites, a thorough understanding of paracentesis is an indispensable skill for all healthcare practitioners involved in patient care.

Understanding Ascites and the Role of Paracentesis Diagnosis

Paracentesis is a medical procedure involving the insertion of a needle into the peritoneal cavity to withdraw ascitic fluid for examination. [^1] When the objective is to analyze this fluid to diagnose the cause of ascites or to rule out infection, it is termed diagnostic paracentesis. This procedure is distinct from therapeutic paracentesis, which focuses on removing large volumes of ascitic fluid to alleviate patient symptoms caused by fluid overload.

Liver cirrhosis is the most frequent cause of ascites. [^2] Patients with cirrhosis-related ascites face a significantly higher mortality risk, with an estimated one-year mortality rate of 20%, compared to 7% for cirrhotic patients without ascites. [^3] Therefore, in all cases of new-onset ascites, sampling the ascitic fluid via paracentesis diagnosis is crucial.

Ascites is broadly classified into two types: exudative and transudative. The serum-ascitic albumin gradient (SAAG) is the most reliable method to differentiate between these types. [^4] SAAG directly reflects portal pressure. A SAAG level of 1.1 g/dL or greater indicates portal hypertension and is characteristic of transudative ascites. Conversely, a SAAG level below 1.1 g/dL suggests exudative ascites. Common causes of transudative ascites include: [^5]

• Hepatic cirrhosis
• Heart failure
• Alcoholic hepatitis
• Fulminant hepatic failure
• Nephrotic syndrome
• Portal vein thrombosis

Exudative ascites can be caused by conditions such as:

• Peritoneal carcinomatosis
• Pancreatitis
• Peritonitis
• Ischemic colitis
• Intestinal obstruction

Anatomical Considerations for Paracentesis

Paracentesis can be performed with the patient in either a lateral decubitus or supine position, and may be guided by imaging techniques. When performed without imaging, the left lower quadrant of the abdomen is generally recommended as the needle insertion site. This location is favored due to a thinner abdominal wall and a deeper accumulation of ascitic fluid, as supported by research. [^6]

Key anatomical factors to consider during paracentesis include:

• Surgical scars: Avoid puncturing through scar tissue to minimize complications.
• Spleen: In the left upper quadrant, the spleen’s location must be considered to prevent accidental puncture.
• Inferior epigastric arteries: These arteries should be avoided to prevent bleeding.
• Cecum: If using the right lower quadrant, the cecum’s position is a consideration.

Percussion is used to determine the ascitic fluid level before needle insertion. The needle is typically inserted in the midline or lower quadrant, lateral to the rectus abdominis muscle, and 2 to 4 cm superomedial to the anterior superior iliac spine. [^7, ^1] This approach is designed to avoid the inferior epigastric arteries. Visible surface veins and surgical scars should be avoided at the insertion site. To minimize ascitic fluid leakage post-procedure, the needle should be inserted at a 45-degree angle or using the Z-track technique.

Indications for Diagnostic and Therapeutic Paracentesis

Diagnostic paracentesis is indicated in several clinical scenarios:

• Suspected Spontaneous Bacterial Peritonitis (SBP): In patients with known ascites presenting with symptoms such as abdominal pain, fever, gastrointestinal bleeding, worsening encephalopathy, new or worsening renal or liver failure, hypotension, or signs of infection, paracentesis diagnosis is crucial to rule out SBP.
• New-Onset Ascites: To determine the underlying cause of newly developed ascites. Fluid analysis can differentiate between transudate and exudate, identify malignant cells, and explore other potential etiologies.

Therapeutic paracentesis is beneficial for:

• Symptom Relief: Alleviating abdominal discomfort or respiratory distress in hemodynamically stable patients with tense ascites or diuretic-resistant ascites. [^7, ^1]

Large-volume paracentesis (LVP) is often necessary for patients with refractory ascites. Innovative systems, such as low-flow pumps that redirect ascitic fluid to the urinary bladder for excretion, have shown promise in improving quality of life and reducing the need for repeated LVP. [^8]

In cases of abdominal compartment syndrome (ACS), while laparotomy is typically required for emergency surgical decompression, LVP can serve as an interim measure to reduce intra-abdominal pressure, especially when tense ascites contributes to ACS. [^9] Furthermore, paracentesis has been shown to improve respiratory function in patients with liver cirrhosis and ascites by enhancing abdominal breathing patterns, ventilatory variables, thoracoabdominal mobility, and reducing dyspnea and fatigue, leading to increased peripheral oxygen saturation. [^10]

Contraindications for Paracentesis

Absolute contraindications for paracentesis are rare. [^11] They include:

• Disseminated Intravascular Coagulation (DIC): Due to the high risk of bleeding.
• Acute Abdomen Requiring Surgery: In situations where surgical intervention is immediately necessary.

Relative contraindications include:

• Pregnancy: Requires careful consideration and often ultrasound guidance.
• Organomegaly: Increased risk of organ puncture.
• Ileus or Intestinal Obstruction: Elevated risk of bowel perforation.
• Distended Bladder: Needs to be emptied prior to the procedure.
• Significant Coagulopathy: Severe thrombocytopenia (platelets < 20 × 10^3/μL) or elevated INR (> 2.0) increase bleeding risk.

It is important to note that coagulopathy and thrombocytopenia, common in cirrhotic patients, are not absolute contraindications because the risk of bleeding complications is generally low. [^12] For patients with severe thrombocytopenia, platelet transfusion may be considered before the procedure, and fresh-frozen plasma (FFP) can be administered to those with elevated INR. In patients without a bleeding history or clinical signs of active bleeding, routine coagulation tests may not be mandatory prior to paracentesis diagnosis. [^12]

During the procedure, it is crucial to avoid inserting the needle or catheter through sites of skin infection, surgical scars, visibly engorged abdominal wall vessels, or hematomas.

Equipment Required for Paracentesis

Prepackaged paracentesis kits, which typically include a plastic sheath cannula attached to a syringe and a stopcock, are readily available. Alternatively, standard large-bore intravenous (IV) catheters or 18-gauge to 20-gauge standard or spinal needles can be used, attached to a syringe for aspiration and IV tubing for drainage. If prepackaged kits are not available, the following equipment is needed:

• Sterile gloves
• Antiseptic swab sticks
• Scalpel, No. 11 blade
• Sterile drapes/towels
• Chlorhexidine or betadine solution
• Lidocaine 1%, 5-mL ampule
• Two 22-gauge injection needles
• 8 French catheter, over 18-gauge × 7.5-inch (19-cm) needle with 3-way stopcock and self-sealing valve
• 25-gauge injection needle
• 20-gauge introducer needle
• 20 ml or 60 ml syringe for fluid sample collection
• Tubing set with roller clamp
• Drainage bag or vacuum container
• 4 × 4 inch (10 × 10 cm) gauze pads
• Three specimen vials or collection bottles (hematology, chemistry, and microbiology sample tubes, plus blood culture bottles) [^11]

Preparation for Paracentesis Diagnosis and Treatment

Consent:

Prior to the procedure, a detailed explanation of the paracentesis procedure, including its risks, benefits, potential complications, and alternative options, must be provided to the patient or their legal representative. Informed consent must be obtained and documented.

Portal of Entry:

The preferred insertion sites are in the right or left lower abdominal quadrants, lateral to the rectus sheath and superior to the anterior superior iliac spine (ASIS). Two commonly recommended entry points are:

• 2 cm below the umbilicus through the linea alba in the midline.
• 5 cm superior and medial to the ASIS on either side.

Positioning:

The lateral decubitus position is often preferred because air-filled bowel loops tend to float, potentially facilitating access to fluid pockets. However, patients with significant ascites may need to be supine. The lateral decubitus position can be particularly helpful in locating fluid pockets in patients with smaller volumes of ascites. Patients should be instructed to empty their bladder before the procedure.

Imaging:

Bedside ultrasound guidance is highly recommended to identify a suitable location for paracentesis. [^13] Ultrasound imaging confirms the presence of fluid (See Figure. Ultrasound for Paracentesis Uses) and helps locate areas with sufficient fluid for aspiration, thereby reducing the risk of unsuccessful attempts and complications. Ultrasound guidance increases the success rate of paracentesis and can prevent unnecessary invasive procedures. [^14] The procedure can be performed after marking the insertion site under ultrasound or in real-time with continuous ultrasound guidance (See Figure. Ultrasound for Paracentesis Uses). Ultrasound also assists in avoiding bowel adhesions or a distended bladder near the entry point. Avoiding prominent veins (caput medusae), scar tissue, and infected skin is crucial for minimizing complications.

Paracentesis Technique and Procedure

While historically paracentesis under ultrasound guidance was primarily used in hospital palliative care settings, home-based palliative paracentesis (HBPP) has emerged as a safe, effective, and convenient option for patients who have difficulty traveling to the hospital. Studies have demonstrated the feasibility and safety of HBPP in managing ascites. [^15] For instance, home-based abdominal paracentesis using a Tenckhoff catheter has been shown to improve symptoms in refractory congestive heart failure patients, reducing the need for peritoneal dialysis exchanges for fluid management. [^16]

Prior to starting the procedure, confirm that the patient’s bladder is empty. Prepare the patient and drape the area in a sterile manner. Cleanse the skin with an antiseptic solution. Administer local anesthesia, typically 1% lidocaine, to the skin and subcutaneous tissue down to the peritoneum at the intended needle or catheter insertion site. Use a 25-gauge needle and a 5 ml syringe to create a small skin wheal of local anesthetic at the entry site. Insert the needle or IV catheter, attached to a syringe or a prepackaged catheter system, perpendicular to the skin or employ the Z-track technique to minimize post-procedure fluid leakage. The Z-track method involves pulling the skin caudally before advancing the needle through the tissues and peritoneum. If using a catheter kit, a small incision with an 11-blade scalpel may facilitate smoother catheter insertion through the skin and subcutaneous tissue.

Apply negative pressure to the syringe during needle or catheter insertion until a loss of resistance is felt and ascitic fluid is aspirated. This is critical to quickly detect inadvertent entry into a blood vessel or other structure. Advance the catheter over the needle into the peritoneal cavity. After collecting sufficient fluid for diagnostic analysis, either remove the needle for a diagnostic tap or connect collection tubing to drain larger volumes of fluid into a vacuum container, plastic canister, or drainage bag for therapeutic paracentesis. Once the desired amount of fluid has been removed, withdraw the catheter and apply pressure to the insertion site to ensure hemostasis. [^7, ^11]

Studies have shown that using wall suction and plastic canisters for fluid drainage during therapeutic paracentesis is a safe and cost-effective alternative to traditional evacuated glass bottles. [^17]

Peritoneal Fluid Analysis in Paracentesis Diagnosis

Ascitic fluid collected during paracentesis should be sent for comprehensive laboratory analysis, including cell count and differential, Gram stain, and fluid culture. Inoculating fluid into bacterial culture bottles at the bedside can enhance culture sensitivity. [^1] Spontaneous bacterial peritonitis (SBP) is diagnosed if the absolute neutrophil count (PMN) in the ascitic fluid is ≥ 250 cells/mm3. [^1, ^11] The PMN count is calculated by multiplying the white blood cell count by the percentage of neutrophils from the differential. Empirical antibiotics, typically a third-generation cephalosporin or a fluoroquinolone, should be initiated in patients with suspected SBP, regardless of the absolute neutrophil count, or in those with a PMN count exceeding the diagnostic threshold.

Additional analyses that may guide inpatient management include albumin, total protein, lactate dehydrogenase (LDH), glucose, cytology, and tumor markers. Albumin levels are particularly important for calculating the SAAG, which helps classify ascites as exudative or transudative, aiding in determining the etiology, especially in identifying portal hypertension. SAAG is calculated by subtracting the ascitic fluid albumin level from the serum albumin level measured on the same day. A SAAG greater than 1.1 g/dL strongly suggests portal hypertension, whereas a SAAG less than 1.1 g/dL makes portal hypertension less likely. [^1, ^18]

Potential Complications of Paracentesis

Paracentesis is generally a safe procedure, but potential complications, although rare, can occur. [^19] These include:

• Persistent Ascitic Fluid Leakage: Fluid leakage from the needle insertion site, often manageable with a simple skin suture.
• Abdominal Wall Hematoma or Bleeding: Bleeding at the puncture site or hematoma formation in the abdominal wall.
• Wound Infection: Infection at the insertion site.
• Perforation of Vessels or Viscera: Extremely rare, but possible injury to surrounding blood vessels or abdominal organs.
• Hypotension: Post-paracentesis hypotension can occur after large volume fluid removal (typically > 5-6 liters). Albumin infusion is often administered after removing large volumes to prevent this complication. [^11, ^20]
• Spontaneous Hemoperitoneum: Bleeding within the peritoneal cavity.
• Catheter Laceration and Loss: Rarely, the catheter can be damaged or lost within the abdominal cavity.
• Hepatorenal Syndrome: A potential complication, particularly in patients with advanced liver disease. [^21]
• Subcutaneous Effusion: Fluid accumulation under the skin due to ascitic fluid leakage. [^22]

Clinical Significance of Paracentesis Diagnosis

Ascites development is a consequence of various disease processes. Paracentesis diagnosis plays a vital role in determining the cause of ascites. By analyzing the peritoneal fluid, it is possible to identify infections, liver disease etiologies, and portal hypertension. Therapeutic paracentesis provides symptomatic relief by removing large volumes of fluid. Utilizing bedside ultrasound to guide the procedure increases the likelihood of successful fluid aspiration and minimizes complications.

Studies have indicated that early paracentesis in patients with SBP can improve mortality rates. [^23] Emergency physicians often play a crucial role in initiating early paracentesis diagnosis in appropriate clinical settings.

Enhancing Healthcare Team Outcomes in Ascites Management

Paracentesis is a relatively straightforward bedside procedure, performed with or without ultrasound guidance to remove ascitic fluid. It is commonly performed by internists, emergency physicians, radiologists, general surgeons, or intensivists for both diagnostic and therapeutic purposes. Diagnostic paracentesis is invaluable in identifying underlying conditions, while therapeutic paracentesis offers rapid symptom relief. However, ascites often recurs, necessitating repeated paracenteses, which can significantly affect a patient’s quality of life.

Close monitoring by nursing staff is essential during and after paracentesis due to potential complications such as hypotension, tachycardia, hemorrhage, fluid leakage, infection, and bowel perforation. [^24, ^25] Nurses are crucial in communicating any adverse signs or symptoms to the physician for timely intervention. Pharmacists ensure accurate dosing of medications used during the procedure and in post-procedure care. Effective interprofessional communication and collaboration are paramount to ensure optimal patient outcomes in the management of ascites and the application of paracentesis diagnosis and treatment.

[^1]: Ong JP. Paracentesis. Am J Gastroenterol. 2006 Sep;101(9):1954-5.
[^2]: Runyon BA., AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009 Jun;49(6):2087-107.
[^3]: Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. 2010 Dec;32(11-12):1343-50.
[^4]: Lichoska-Josifovikj F, Grivceva-Stardelova K, Todorovska B, Andreevski V, Nikolov F, Adem D. THE VALUE OF SERUM-ASCITES ALBUMIN GRADIENT AS A PREDICTOR OF SPONTANEOUS BACTERIAL PERITONITIS IN PATIENTS WITH LIVER CIRRHOSIS AND ASCITES. Georgian Med News. 2022 Sep;(330):23-25.
[^5]: Angeleri A, Rocher A, Caracciolo B, Pandolfo M, Palaoro L, Perazzi B. New Biochemical Parameters in the Differential Diagnosis of Ascitic Fluids. Gastroenterology Res. 2016 Feb;9(1):17-21.
[^6]: Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005 Oct;25(5):984-6.
[^7]: Thomsen TW, Shaffer RW, White B, Setnik GS. Videos in clinical medicine. Paracentesis. N Engl J Med. 2006 Nov 09;355(19):e21.
[^8]: Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. J Hepatol. 2017 Nov;67(5):940-949.
[^9]: Allen R, Sarani B. Evaluation and management of intraabdominal hypertension. Curr Opin Crit Care. 2020 Apr;26(2):192-196.
[^10]: Wittmer VL, Lima RT, Maia MC, Duarte H, Paro FM. RESPIRATORY AND SYMPTOMATIC IMPACT OF ASCITES RELIEF BY PARACENTESIS IN PATIENTS WITH HEPATIC CIRRHOSIS. Arq Gastroenterol. 2020 Jan-Mar;57(1):64-68.
[^11]: McGibbon A, Chen GI, Peltekian KM, van Zanten SV. An evidence-based manual for abdominal paracentesis. Dig Dis Sci. 2007 Dec;52(12):3307-15.
[^12]: McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991 Feb;31(2):164-71.
[^13]: Millington SJ, Koenig S. Better With Ultrasound: Paracentesis. Chest. 2018 Jul;154(1):177-184.
[^14]: Nazeer SR, Dewbre H, Miller AH. Ultrasound-assisted paracentesis performed by emergency physicians vs the traditional technique: a prospective, randomized study. Am J Emerg Med. 2005 May;23(3):363-7.
[^15]: Ota KS, Schultz N, Segaline NA. Palliative Paracentesis in the Home Setting: A Case Series. Am J Hosp Palliat Care. 2021 Aug;38(8):1042-1045.
[^16]: Kunin M, Mini S, Abu-Amer N, Beckerman P. Regular at-home abdominal paracentesis via Tenckhoff catheter in patients with refractory congestive heart failure. Int J Clin Pract. 2021 Dec;75(12):e14924.
[^17]: Kelil T, Shyn PB, Wu LE, Levesque VM, Kacher D, Khorasani R, Silverman SG. Wall suction-assisted image-guided therapeutic paracentesis: a safe and less expensive alternative to evacuated bottles. Abdom Radiol (NY). 2016 Jul;41(7):1333-7.
[^18]: Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol. 2016 Feb 28;8(6):307-21.
[^19]: Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986 Nov;146(11):2259-61.
[^20]: De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, Giostra E, Hadengue A. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009 Aug;7(8):906-9.
[^21]: Duggal P, Farah KF, Anghel G, Marcus RJ, Lupetin AR, Babich MM, Sandroni SE, McGill RL. Safety of paracentesis in inpatients. Clin Nephrol. 2006 Sep;66(3):171-6.
[^22]: Otsuka Y, Nagaoka H, Nakano Y, Sakae H, Hasegawa K, Otsuka F. Subcutaneous edema as rare complication of abdominal paracentesis. Clin Case Rep. 2021 Nov;9(11):e05116.
[^23]: Abdu B, Akolkar S, Picking C, Boura J, Piper M. Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis. Dig Dis Sci. 2021 Nov;66(11):4035-4045.
[^24]: Ning S, Yang Y, Wang C, Luo F. Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review. BMC Surg. 2019 Apr 25;19(1):42.
[^25]: Jun Jie NG, Teo KA, Shabbir A, Yeo TT. Widespread Intra-abdominal Carcinomatosis from a Rhabdoid Meningioma after Placement of a Ventriculoperitoneal Shunt: A Case Report and Review of the Literature. Asian J Neurosurg. 2018 Jan-Mar;13(1):176-183.